| Product NDC: | 10147-1700 |
| Proprietary Name: | itraconazole |
| Non Proprietary Name: | ITRACONAZOLE |
| Active Ingredient(s): | 100 mg/1 & nbsp; ITRACONAZOLE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 10147-1700 |
| Labeler Name: | Patriot Pharmaceuticals |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020083 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20050201 |
| Package NDC: | 10147-1700-7 |
| Package Description: | 7 POUCH in 1 DOSE PACK (10147-1700-7) > 1 BLISTER PACK in 1 POUCH > 4 CAPSULE in 1 BLISTER PACK |
| NDC Code | 10147-1700-7 |
| Proprietary Name | itraconazole |
| Package Description | 7 POUCH in 1 DOSE PACK (10147-1700-7) > 1 BLISTER PACK in 1 POUCH > 4 CAPSULE in 1 BLISTER PACK |
| Product NDC | 10147-1700 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ITRACONAZOLE |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20050201 |
| Marketing Category Name | NDA |
| Labeler Name | Patriot Pharmaceuticals |
| Substance Name | ITRACONAZOLE |
| Strength Number | 100 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Azole Antifungal [EPC],Azoles [Chemical/Ingredient] |